XML 45 R35.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
SCHEDULE OF STOCK OPTION PLAN ACTIVITY

A summary of stock option activity under the Plans for the three months ended March 31, 2025 is as follows:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life   Aggregate Intrinsic Value 
Options outstanding – January 1, 2025   2,469,099   $6.49           
Options granted   30,000   $35.96           
Options exercised   (2,743)  $8.44           
Options cancelled/forfeited   (32,205)  $11.19           
Options outstanding – March 31, 2025   2,464,151   $6.78    2.97   $49,489,000 
Options exercisable   2,243,882   $5.56    2.41   $47,202,000 
Options vested and expected to vest   2,436,256   $6.61    2.90   $49,250,000 
SCHEDULE OF FAIR VALUE ASSUMPTIONS

The table below illustrates the fair value per share determined using the Black-Scholes-Merton option pricing model with the following assumptions used for valuing options granted to employees:

 

   2025 
Weighted-average fair value of options granted  $24.13 
Expected terms (in years)   6.11 
Expected volatility   71.19%
Risk-free interest rate   4.53%
Dividend yield   - 
SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE

The following table summarizes information about stock options outstanding and exercisable at March 31, 2025:

   

   Options Outstanding   Options Exercisable 
Range of Exercise Prices  Number Outstanding   Weighted Average Remaining Contractual Life in Years  

Weighted

Average

Exercise

Price

  

Number

Exercisable

  

Weighted

Average

Exercise

Price

 
$1.47 - $1.70   31,942    2.46   $1.68    31,942   $1.68 
$1.73   250,000    2.76   $1.73    250,000   $1.73 
$2.23   270,000    1.84   $2.23    270,000   $2.23 
$2.40 - $2.60   14,068    1.83   $2.57    14,068   $2.57 
$3.95   308,500    1.00   $3.95    308,500   $3.95 
$4.49 - $5.72   92,300    4.36   $5.53    92,300   $5.53 
$6.30   285,000    3.89   $6.30    285,000   $6.30 
$6.75 - $7.26   43,349    7.27   $6.84    24,139   $6.81 
$7.30   274,500    4.76   $7.50    274,500   $7.30 
$7.60 - $45.64   894,492    2.88   $10.92    693,433   $8.17 
$1.47 - $45.64   2,464,151    2.97   $6.78    2,243,882   $5.56 
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY

A summary of the Company’s RSU activity and related information for the three months ended March 31, 2025 is as follows:

 

   Number of Shares   Weighted Average Grant Date Fair Value 
RSUs unvested - January 1, 2025   353,112   $22.55 
RSUs granted   -    - 
RSUs vested   (17,410)   17.85 
RSUs cancelled/forfeited   (20,000)   17.97 
RSUs unvested - March 31, 2025   315,702   $23.10 
SCHEDULE OF PERFORMANCE STOCK UNITS ACTIVITY

A summary of the Company’s PSU activity and related information for the three months ended March 31, 2025 is as follows:

 

   Number of Shares   Weighted Average Grant Date Fair Value 
PSUs unvested – January 1, 2025   1,567,913   $18.56 
PSUs granted   -      
PSUs vested   -      
PSUs cancelled/forfeited   -      
PSUs unvested – March 31, 2025   1,567,913   $18.56 
SCHEDULE OF STOCK BASED COMPENSATION GRANTED TO EMPLOYEES, DIRECTORS AND CONSULTANTS

The Company recorded stock-based compensation related to equity instruments granted to employees, directors and consultants as follows:

 

   2025   2024 
  

For the Three Months

Ended March 31,

 
   2025   2024 
Employees - selling, general and administrative  $3,794,000   $3,525,000 
Employees – research and development   422,000    439,000 
Directors - selling, general and administrative   226,000    188,000 
Consultants - selling, general and administrative   114,000    17,000 
Total  $4,556,000   $4,169,000